WestEnd Advisors’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.89K | Hold |
4
| – | – | ﹤0.01% | 161 |
|
|
2025
Q4 | $1.87K | Sell |
4
-1
| -20% | -$464 | ﹤0.01% | 166 |
|
|
2025
Q3 | $2.13K | Sell |
5
-2
| -29% | -$775 | ﹤0.01% | 151 |
|
|
2025
Q2 | $2.68K | Hold |
7
| – | – | ﹤0.01% | 132 |
|
|
2025
Q1 | $2.42K | Buy |
7
+5
| +250% | +$1.61K | ﹤0.01% | 139 |
|
|
2024
Q4 | $600 | Hold |
2
| – | – | ﹤0.01% | 159 |
|
|
2024
Q3 | $813 | Hold |
2
| – | – | ﹤0.01% | 140 |
|
|
2024
Q2 | $643 | Sell |
2
-1
| -33% | -$325 | ﹤0.01% | 145 |
|
|
2024
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 114 |
|
|
2023
Q4 | $812 | Hold |
3
| – | – | ﹤0.01% | 123 |
|
|
2023
Q3 | $738 | Buy |
+3
| New | +$821 | ﹤0.01% | 126 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | -$508 | – | 122 |
|
|
2022
Q4 | $480 | Sell |
2
-1
| -33% | -$224 | ﹤0.01% | 147 |
|
|
2022
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 111 |
|
|
2022
Q2 | $504 | Buy |
+3
| New | +$645 | ﹤0.01% | 133 |
|
|
2022
Q1 | – | Sell |
-2
| Closed | -$502 | – | 154 |
|
|
2021
Q4 | $513 | Buy |
+2
| New | +$489 | ﹤0.01% | 155 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 150 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 164 |
|
|
2019
Q1 | – | Sell |
-35
| Closed | -$4.36K | – | 57 |
|
|
2018
Q4 | $4.36K | Hold |
35
| – | – | ﹤0.01% | 47 |
|
|
2018
Q3 | $4.87K | Hold |
35
| – | – | ﹤0.01% | 44 |
|
|
2018
Q2 | $3.59K | Hold |
35
| – | – | ﹤0.01% | 42 |
|
|
2018
Q1 | $3.4K | Hold |
35
| – | – | ﹤0.01% | 43 |
|
|
2017
Q4 | $3.07K | Hold |
35
| – | – | ﹤0.01% | 43 |
|
|
2017
Q3 | $2.79K | Hold |
35
| – | – | ﹤0.01% | 37 |
|
|
2017
Q2 | $3.05K | Hold |
35
| – | – | ﹤0.01% | 35 |
|
|
2017
Q1 | $3.12K | Hold |
35
| – | – | ﹤0.01% | 36 |
|
|
2016
Q4 | $2.59K | Sell |
35
-110
| -76% | -$8.24K | ﹤0.01% | 34 |
|
|
2016
Q3 | $11K | Sell |
145
-1,199,150
| -100% | -$91.8M | ﹤0.01% | 33 |
|
|
2016
Q2 | $92.4M | Sell |
1,199,295
-227,782
| -16% | -$18M | 4.9% | 15 |
|
|
2016
Q1 | $111M | Buy |
1,427,077
+197,860
| +16% | +$13.8M | 5.4% | 2 |
|
|
2015
Q4 | $83.1M | Buy |
1,229,217
+51,918
| +4% | +$3.62M | 4.07% | 17 |
|
|
2015
Q3 | $91.1M | Sell |
1,177,299
-306,379
| -21% | -$27.1M | 4.61% | 16 |
|
|
2015
Q2 | $135M | Sell |
1,483,678
-87,033
| -6% | -$6.97M | 6.23% | 1 |
|
|
2015
Q1 | $118M | Buy |
1,570,711
+100,024
| +7% | +$7.18M | 5.31% | 2 |
|
|
2014
Q4 | $108M | Buy |
1,470,687
+34,253
| +2% | +$2.41M | 4.93% | 10 |
|
|
2014
Q3 | $101M | Buy |
+1,436,434
| New | +$94.9M | 5.12% | 4 |
|
Other funds holding HCA
VCM
VPM
WestEnd Advisors's HCA Position: Q1 2026 in Review
WestEnd Advisors held its HCA Healthcare (HCA) position steady in Q1 2026 at 4 shares worth $1.89K. The position accounts for ﹤0.01% of the portfolio, ranked #161.
WestEnd Advisors first reported a position in HCA in Q3 2014 and has held it in 33 quarters since. The position peaked at $135M in Q2 2015. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- WestEnd Advisors held 4 shares of HCA Healthcare worth $1.89K as of Q1 2026.
- WestEnd Advisors left its HCA Healthcare share count unchanged in Q1 2026.
- HCA Healthcare made up ﹤0.01% of WestEnd Advisors's portfolio in Q1 2026, its #161 holding.
- WestEnd Advisors first reported a position in HCA Healthcare in Q3 2014 and has held it in 33 quarters since.
- WestEnd Advisors's HCA Healthcare position peaked at $135M in Q2 2015.
- 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on WestEnd Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.